Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations.

Autor: Burgard C; Department of Nuclear Medicine, Saarland University-Medical Center, 66421 Homburg, Germany., Rosar F; Department of Nuclear Medicine, Saarland University-Medical Center, 66421 Homburg, Germany., Marlowe RJ; Spencer-Fontayne Corporation, Jersey City, NJ 07304, USA., Bartholomä M; Department of Nuclear Medicine, Saarland University-Medical Center, 66421 Homburg, Germany., Dewes S; Department of Nuclear Medicine, Saarland University-Medical Center, 66421 Homburg, Germany., Schaefer-Schuler A; Department of Nuclear Medicine, Saarland University-Medical Center, 66421 Homburg, Germany., Linxweiler J; Department of Urology, Saarland University-Medical Center, 66421 Homburg, Germany., Khreish F; Department of Nuclear Medicine, Saarland University-Medical Center, 66421 Homburg, Germany., Ezziddin S; Department of Nuclear Medicine, Saarland University-Medical Center, 66421 Homburg, Germany.

Publikováno v: Cancers [Cancers (Basel)] 2023 May 03; Vol. 15 (9). Date of Electronic Publication: 2023 May 03.

Early molecular imaging response assessment based on determination of total viable tumor burden in [ ⁶⁸ Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [ ¹⁷⁷ Lu]Lu-PSMA-617 radioligand therapy.

Autor: Rosar F; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany., Wenner F; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany., Khreish F; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany., Dewes S; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany., Wagenpfeil G; Department of Biostatistics, Saarland University, Homburg, Germany., Hoffmann MA; Department of Nuclear Medicine, Johannes Gutenberg-University, Mainz, Germany., Schreckenberger M; Department of Nuclear Medicine, Johannes Gutenberg-University, Mainz, Germany., Bartholomä M; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany., Ezziddin S; Department of Nuclear Medicine, Saarland University - Medical Center, Kirrberger Str. 100, Geb. 50, 66421, Homburg, Germany. samer.ezziddin@uks.eu.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Apr; Vol. 49 (5), pp. 1584-1594. Date of Electronic Publication: 2021 Nov 02.

Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer.

Autor: Vogel MME; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Institute for Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany., Dewes S; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany., Sage EK; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany., Devecka M; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany., Eitz KA; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Institute for Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany., Gschwend JE; Department of Urology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany., Eiber M; Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany., Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Institute for Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany., Schiller K; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.

Publikováno v: Frontiers in oncology [Front Oncol] 2021 Jul 30; Vol. 11, pp. 715020. Date of Electronic Publication: 2021 Jul 30 (Print Publication: 2021).

Current Clinical Applications of PSMA-PET for Prostate Cancer Diagnosis, Staging, and Treatment.

Autor: von Stauffenberg, Franz¹ (AUTHOR) franz.vonstauffenberg@usz.ch, Poyet, Cédric² (AUTHOR) cedric.poyet@stadtspital.ch, Beintner-Skawran, Stephan³ (AUTHOR) stephan.beintner-skawran@usz.ch, Maurer, Alexander³ (AUTHOR) alexander.maurer@usz.ch, Schmid, Florian A.¹ (AUTHOR) florian.schmid@usz.ch

Publikováno v: Cancers. Dec2024, Vol. 16 Issue 24, p4263. 21p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.